This site uses cookies, including third-party cookies, that help us to provide and improve our services. Read More

Immunoassay Market

Immunoassay Market

Immunoassay Market Analysis, By Technology (Chemiluminescence Immunoassay, Enzyme-linked Immunosorbent Assay, Enzyme Linked Fluorescence Assay, Radioimmunoassay), By Product (Analyzer, Consumables), By Application-Global Market Insights 2020 to 2026

Immunoassay Market
FACT4766MR
  • Mar-2022
  • List of Tables : 90
  • List of Figures : 88
  • 170 Pages
  • Healthcare

Immunoassay Market Outlook (2020 to 2026)

Intense developments in the field of genomics and proteomics has expanded the database of biomarkers used by industry players to develop new assays that cascade the onset of a disease or disorder. The global immunoassays market is set to register impressive growth, expanding at a healthy 6.0% CAGR during the forecast period (2020-2026).

Key players are investing in the development of novel immunoassays in the infectious diseases domain, with increasing database on genetics and biomarkers of various infectious pathogens. Immunoassay analyzers such as enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA) and immunofluorescence assay (IFA) are preferred choices for the diagnosis of infectious diseases.

Immunoassay Manufacturers: Strategies

Rising demand for early detection and diagnosis of autoimmune disorders has also augmented development of new immunoassay systems by leading players in the in-vitro diagnostics industry. For instance, in December 2017, Innova diagnostics launched the next-generation EIA & IFA Processor QUANTA-Lyser 3000 for the diagnosis of autoimmune disorders in clinical laboratories.

In addition, the current COVID-19 pandemic has also prompted key players to invest heavily in the development of immunoassays to eradicate the SARS-CoV-2 virus. For instance, Bio-Rad Corporation announced the launch of a blood-immunoassay kit for the identification of antibodies to the novel coronavirus in April 2020.

Immunoassay Manufacturer Insights: Development of Advanced Immunoassay to Drive Market Players’ Growth

The global immunoassay market is highly consolidated. The top four market players constitute more than half of the total market share. These players are: F. Hoffmann La-Roche Ltd. (Roche Holdings AG), Abbott Laboratories, Siemens Healthineers and Beckman Coulter, Inc. (Danaher). These players have consolidated their operations by virtue of important collaborations to burgeon production of immunoassay kits.

La-Roche, for instance, offers products such as the COBAS C 702 & E 602 Module, the COBAS 4000 & 6000 Analyzer series and Elecsys Assays. Likewise, Abbott Laboratories offers biotin-free assays to prevent interference in testing and the resulting inaccuracies. Other prominent immunoassay players include DiaSorin S.p.A., Sysmex Corporation, bioMerieux SA, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company and Merck KGaA.

Key Companies Profiled

  • DiaSorin S.p.A.
  • Sysmex Corporation
  • bioMerieux SA
  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific Inc.
  • Becton
  • Dickinson and Company 
  • Merck KGaA.

COVID-19’s Impact on Global Immunoassay Market:

The COVID-19 pandemic is anticipated to heighten growth prospects for the global immunoassay market, as companies are increasingly directing research and development towards developing robust testing systems to ascertain potential antibodies which may assist in eradicating the novel coronavirus.

Laboratories and diagnostic companies across the world are racing to produce antibody tests. Serology-based testing is in particularly high demand. This is attributed to its ability to quantify the number of COVID-19 cases, including those who may be asymptomatic or have recovered. ELISA-based testing is equally gaining traction in this regard. At present, Epitope Diagnostics, Inc. is offering the EDI Novel Coronavirus COVID-19 ELISA kits for qualitative detection of the COVID-19 IgG and IgM in human serum.

More recently, Bio-Rad Corporation announced the launch of a blood-based immunoassay kit for the identification of antibodies to the SARS-CoV-2. The company has established preliminary performance of the assay and has been clinically evaluated in multiple hospitals to further confirm its performance.

Also, Thermo Fisher Scientific is offering its Singleplex kit for SARS-CoV-2 pathogen detection which is based on the RT-PCR technique. Furthermore, the company predicted that COVID-19 testing could create a tailwind of US$ 750 million in the second quarter of 2020. However, the benefits are more likely to be offset by disruptions, leading to an overall decline in the company’s sales by around 15%.

Avail customized purchase options for your needs

Analyst’s Viewpoint:

“Introduction of integrated systems coupled with development of ultrasensitive analyzer systems are anticipated to leverage prospects for the global immunoassay market. In addition, the novel coronavirus outbreak has provided a pathway for market expansion. North America and the Asia-Pacific regions are anticipated to provide credible growth opportunities, attributed to increased forays by leading market players to penetrate into respective markets.”

Global Immunoassay Market Report Scope

The recent study undertaken by Fact.MR on the global immunoassay market incorporates a six-year forecast period ranging from 2020 to 2026. The report elaborates on the key drivers, opportunities and restraints existing for the global immunoassay market in the future. The report incorporates a detailed assessment of key segments in terms of their revenue, market share and growth rate. Market segmentation has been done on the basis of technology, product, application and end-user.

A section on regional analysis has been embedded in the report. The regional analysis has been carried out for the following geographies: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa (MEA).

Each region incorporates the segmental analysis mentioned above. In addition, a competitive landscape detailing key players’ market and revenue shares, strategies for expansion, key collaborations and SWOT analysis, has been incorporated within the scope of this report. Overall, the report presents an optimistic scenario of the global immunoassay market.

An Adaptive Approach to Modern-day Research Needs

Global Immunoassays: Market Segmentation

Fact.MR has studied the global immunoassays market with detailed segmentation on the basis of technology, product, application, end-user, and region.

  • By Technology :

    • Chemiluminescence Immunoassay (CLIA)
    • Enzyme-linked Immunosorbent Assay (ELISA)
    • Enzyme Linked Fluorescence Assay (ELFA)
    • Radioimmunoassay (RIA)
    • Others
  • By Product :

    • Analyzer
    • Consumables
  • By Application :

    • Infectious Diseases
    • Endocrinology
    • Oncology
    • Cardiology
    • Orthopedics
    • Others
  • By End-user :

    • Hospitals & Diagnostic Laboratories
    • Blood Banks
    • Others (Pharmaceutical & Biotech Companies, Academic & Research Institutes, Forensic Labs, etc.)
  • By Region :

    • North America
    • Europe
    • Asia Pacific
    • Eastern Europe
    • Latin America
    • Middle East & Africa (MEA)

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than the addressee(s) is unauthorized and prohibited.”

- FAQs -

The global immunoassays market expects impressive growth at a healthy 6.0% CAGR through 2026.
The top four market players are F. Hoffmann La-Roche Ltd. (Roche Holdings AG), Abbott Laboratories, Siemens Healthineers and Beckman Coulter, Inc. (Danaher).
North America and the Asia-Pacific regions are anticipated to provide credible growth opportunities for the immunoassays market.
Immunoassay Market is segmented on the basis of Technology, Product, Application, End User, And Region.

Need an Exclusive Report for your Unique Requirement?

- Related Reports -

Surgical AR systems market

Surgical AR Systems Market research report covers detailed information on Global Surgical AR Systems...

Skeletal Deformation Correction Market

Skeletal Deformation Correction Market research report covers detailed information on Global Skeleta...

Leukocytoclastic Vasculitis Market

Leukocytoclastic Vasculitis Market is expected to witness growth on the back of rising blood vessel ...

Home Respiratory Therapy Market

Home Respiratory Therapy Market is expected to grow positively during, 2020-2030. Chronic obstructiv...

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.